EMG Analysis in ABI: Motor Imagery and Action

October 2, 2025 updated by: Ana María Martín Nogueras, University of Salamanca

Upper Limb Electromyographic Response to Motor Imagery and Action Observation in Acquired Brain Injury Patients.

This study focuses on electromyographic analysis of upper limb muscle activation in stroke survivors during Motor Imagery (MI) and Action Observation (AO) rehabilitation techniques. By measuring muscle activity in the wrist and finger flexors and extensors, the research seeks to understand the impact of MI and AO on motor function recovery post-stroke. Conducted at the University of Salamanca, the study involves stroke survivors participating in a series of three experimental sessions. The analysis will correlate electromyographic responses with functional independence, limb functionality, and cognitive factors. The research aims to contribute to the fields of occupational therapy and physiotherapy, offering insights into effective rehabilitation methods for improving quality of life in stroke survivors.

Study Overview

Detailed Description

This study investigates muscle activation in the upper limbs of stroke survivors using electromyographic analysis during Motor Imagery (MI) and Action Observation (AO). Stroke, a major cause of disability, often results in motor impairments in the upper limb, impacting daily activities. The research focuses on innovative rehabilitation techniques based on neuroplasticity, such as MI and AO, stimulated by the discovery of mirror neurons.

The primary goal is to record upper limb muscle activation during MI and AO, using surface electromyography to measure activation in wrist and finger flexors and extensors. The study will also explore the relationship between electromyographic responses and factors like daily activity independence, limb functionality, quality of life, mental evocation ability, and cognitive impairment.

Conducted at the University of Salamanca, the study will recruit stroke survivors for a three-session experimental protocol involving control, MI, and AO conditions. Data will be analyzed with SPSS Statistics, ensuring anonymity and ethical compliance. The research aims to enhance understanding of effective neurorehabilitation techniques, contributing to the fields of occupational therapy and physiotherapy.

Study Type

Interventional

Enrollment (Estimated)

28

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Ana MAría Martín Nogueras, Dr
  • Phone Number: 677510296
  • Email: anamar@usal.es

Study Locations

    • Salamanca
      • Salamanca, Salamanca, Spain, 37007
        • Recruiting
        • Universidad de Salmanca
        • Contact:
        • Principal Investigator:
          • Beatriz María Bermejo Gil, Dr
        • Contact:
          • Ana María Martín Nogueras
          • Phone Number: 677510296
          • Email: anamar@usal.es
        • Principal Investigator:
          • Sara Santiago Marín, Phd Student
        • Principal Investigator:
          • AnaBelen Calvo Vera, Dr
        • Principal Investigator:
          • Ana María Martín Nogueras, Dr

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Being over 18 years of age
  • Diagnoses of established stroke
  • Present limitations or motor response deficiencies in the upper limb
  • Maintain cognitive functions with the ability to follow the instructions of the interventions and evaluations (MOCA>14)

Exclusion Criteria:

  • Diagnosed with mental illness before the stroke
  • Other systemic conditions on the central nervous system
  • Cardiorespiratory system pathologies in severe cases
  • Acute period, fever, muscle inflammation or myopathies
  • Any type of vascular and organic insufficiency
  • Liver disease or skin lesions in the area of application of the electrodes.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group

The intervention group will receive 3 experimental procedures

  1. Placebo control
  2. Motor Imagery- Active Comparator
  3. Action Observation (OA) Active comparator muscle activation control by surface electromyography will be recorded in these three situations
mental process where an individual visualizes or imagines themselves performing a movement without actually executing it physically. This cognitive process involves the mental rehearsal of motor actions, engaging similar neural pathways that are used when physically performing the action.
rehabilitation technique based on the principle of observing actions to improve motor function and learning. This approach is rooted in the concept of the mirror neuron system, a group of neurons that are activated both when a person performs an action and when they observe the same action performed by others.
Recording with images of landscapes without the presence of any person or animal that could evoke MI or OA.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Disability and Dependence Level - Barthel Index
Time Frame: Administered once, typically taking a few minutes.
A general measure assessing patient independence, evaluating performance in basic daily activities (ADLs).
Administered once, typically taking a few minutes.
Upper Limb Functionality - Action Research Arm Test (ARAT)
Time Frame: Administration time ranges from 5 to 15 minutes.
Assesses upper limb functionality post-cortical injury, involving manipulation tasks with various objects.
Administration time ranges from 5 to 15 minutes.
Cognitive Impairment - Montreal Cognitive Assessment (MoCA)
Time Frame: takes about 10 minutes for administration.
Evaluates mild cognitive dysfunctions across multiple domains, including attention, memory, language, and executive functions.
takes about 10 minutes for administration.
Perception Impairment - Loewenstein Occupational Therapy Cognitive Assessment (LOTCA)
Time Frame: Duration varies based on the number and type of subtests administered.
Specific for occupational therapy in stroke patients, assessing visual, spatial, motor, and cognitive perception.
Duration varies based on the number and type of subtests administered.
Mental Evocation Ability - Mental Evocation of Images, Movements, and Activities Questionnaire (CEMIMA)
Time Frame: Duration varies
Measures the ability to mentally form visual and kinesthetic images of the hand/upper limb.
Duration varies
Quality of Life Perception - Stroke Impact Scale 16 (SIS-16)
Time Frame: 5-10 minutes.
A self-report measure focusing on physical aspects including strength, hand function, mobility, and ADLs.
5-10 minutes.
Electromyographic Activity During MI and AO
Time Frame: during the experimental setup
muscle activity using surface electrodes on wrist extensors and flexors.
during the experimental setup

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Age
Time Frame: 1 minute
birth age
1 minute
gender
Time Frame: 1 minute
he gender with which the participant identifies
1 minute
Marital Status
Time Frame: 1 minute
single, married, divorced
1 minute
Education Level
Time Frame: 1 minute
he highest level of education
1 minute
Economic Status
Time Frame: 1 minute
participant's economic
1 minute
Affected Side
Time Frame: 1 minute
The side of the body affected by the stroke or injury
1 minute
Dominant Side
Time Frame: 1 minute
The side of the body that is the participant's natural dominant side
1 minute
Type of Lesion
Time Frame: 1 minute
specific type of brain injury
1 minute
Time Since Injury
Time Frame: 1 minute
time since the participant had the brain injury or stroke.
1 minute

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2024

Primary Completion (Estimated)

January 30, 2026

Study Completion (Estimated)

January 30, 2027

Study Registration Dates

First Submitted

January 19, 2024

First Submitted That Met QC Criteria

January 19, 2024

First Posted (Actual)

January 30, 2024

Study Record Updates

Last Update Posted (Estimated)

October 7, 2025

Last Update Submitted That Met QC Criteria

October 2, 2025

Last Verified

October 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Motor Imagery (MI)

Subscribe